Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations - PubMed (original) (raw)
Comparative Study
Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations
G Nucifora et al. Proc Natl Acad Sci U S A. 1994.
Abstract
Two genes have been implicated in leukemias of patients with abnormalities of chromosome 3, band q26: EVI1, which can be activated over long distances by chromosomal rearrangements involving 3q26, and EAP, a ribosomal gene that fuses with AML1 in a therapy-related myelodysplasia patient with a t(3;21)(q26.2;q22). AML1 was identified by its involvement in the t(8;21)(q22;q22) of acute myeloid leukemia. Here we report the consistent identification of fusion transcripts between AML1 and EAP or between AML1 and previously unidentified sequences that we named MDS1 (MDS-associated sequences) in the leukemic cells of four patients with therapy-related myelodysplasia/acute myeloid leukemia and in one patient with chronic myelogenous leukemia in blast crisis, all of whom had a t(3;21). In addition, we have identified a third chimeric transcript, AML1/EVI1, in one of the therapy-related acute myeloid leukemia patients. Pulsed-field gel electrophoresis established the order of the genes as EAP, the most telomeric, and EVI1, the most centromeric, gene. The results indicate that translocations could involve multiple genes and affect gene expression over long distances.
Similar articles
- Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
Fears S, Mathieu C, Zeleznik-Le N, Huang S, Rowley JD, Nucifora G. Fears S, et al. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1642-7. doi: 10.1073/pnas.93.4.1642. Proc Natl Acad Sci U S A. 1996. PMID: 8643684 Free PMC article. - The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
Zent CS, Mathieu C, Claxton DF, Zhang DE, Tenen DG, Rowley JD, Nucifora G. Zent CS, et al. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1044-8. doi: 10.1073/pnas.93.3.1044. Proc Natl Acad Sci U S A. 1996. PMID: 8577711 Free PMC article. - The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F, Pisegna S, Diverio D. Lo Coco F, et al. Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review. - The EVI1 gene in myeloid leukemia.
Nucifora G. Nucifora G. Leukemia. 1997 Dec;11(12):2022-31. doi: 10.1038/sj.leu.2400880. Leukemia. 1997. PMID: 9447815 Review.
Cited by
- Phenotypic heterogeneity in individuals with MECOM variants in 2 families.
Niihori T, Tanoshima R, Sasahara Y, Sato A, Irie M, Saito-Nanjo Y, Funayama R, Shirota M, Abe T, Okuyama Y, Ishii N, Nakayama K, Kure S, Imaizumi M, Aoki Y. Niihori T, et al. Blood Adv. 2022 Sep 27;6(18):5257-5261. doi: 10.1182/bloodadvances.2020003812. Blood Adv. 2022. PMID: 35020829 Free PMC article. No abstract available. - Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia.
Ochi Y, Ogawa S. Ochi Y, et al. Cancers (Basel). 2021 Mar 11;13(6):1232. doi: 10.3390/cancers13061232. Cancers (Basel). 2021. PMID: 33799787 Free PMC article. Review. - EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.
Birdwell C, Fiskus W, Kadia TM, DiNardo CD, Mill CP, Bhalla KN. Birdwell C, et al. Blood Cancer J. 2021 Mar 22;11(3):64. doi: 10.1038/s41408-021-00457-9. Blood Cancer J. 2021. PMID: 33753715 Free PMC article. Review. - EVI1 in Leukemia and Solid Tumors.
Liang B, Wang J. Liang B, et al. Cancers (Basel). 2020 Sep 18;12(9):2667. doi: 10.3390/cancers12092667. Cancers (Basel). 2020. PMID: 32962037 Free PMC article. Review. - Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.
Bavaro L, Martelli M, Cavo M, Soverini S. Bavaro L, et al. Int J Mol Sci. 2019 Dec 5;20(24):6141. doi: 10.3390/ijms20246141. Int J Mol Sci. 2019. PMID: 31817512 Free PMC article. Review.
References
- Blood. 1985 Dec;66(6):1362-70 - PubMed
- EMBO J. 1994 Feb 1;13(3):504-10 - PubMed
- Am J Hum Genet. 1988 Oct;43(4):442-51 - PubMed
- Mol Cell Biol. 1989 May;9(5):2105-13 - PubMed
- Oncogene. 1990 Jul;5(7):963-71 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous